Highmark BCBS to Cover MDxHealth Prostate Cancer Test
News Oct 07, 2016
MDxHealth SA has announced that the Highmark BCBS (Highmark) has issued a positive medical coverage policy decision for the ConfirmMDx® for Prostate Cancer test. This positive coverage policy is in line with the positive medical policy recently implemented by Independence Blue Cross and represents the second Blue Cross Blue Shield Association (BCBSA) licensee to establish coverage for commercial and Medicare members for ConfirmMDx.
Highmark is a national, diversified health care partner based in Pittsburgh that serves members across the United States through businesses in health insurance, dental insurance, vision care and reinsurance. Highmark, and its affiliates, operate health insurance plans in Pennsylvania, Delaware and West Virginia that serve 5.2 million members. Highmark is among the largest health insurers in the United States and is the fourth largest Blue Cross and Blue Shield-affiliated company.
"Highmark Blue Cross Blue Shield's positive policy decision adds to the momentum we are seeing in payer adoption of the ConfirmMDx for Prostate Cancer test," stated Dr. Jan Groen, CEO of MDxHealth. "This decision further validates the impact ConfirmMDx has on patient outcomes and reduction in cost to the US healthcare system."
Are Stem Cells the Link Between Bacteria and Cancer?News
New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection.READ MORE
Cambridge Epigenetix, NuGEN Technologies Sign Agreement to Combine Leading Technologies in Epigenetics ResearchNews
Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.READ MORE